Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip.

ABSTRACT: Genome-wide association studies are revolutionizing the search for the genes underlying human complex diseases. The main decisions to be made at the design stage of these studies are the choice of the commercial genotyping chip to be used and the numbers of case and control samples to be genotyped. The most common method of comparing different chips is using a measure of coverage, but this fails to properly account for the effects of sample size, the genetic model of the disease, and linkage disequilibrium between SNPs. In this paper, we argue that the statistical power to detect a causative variant should be the major criterion in study design. Because of the complicated pattern of linkage disequilibrium (LD) in the human genome, power cannot be calculated analytically and must instead be

SUBMITTER: Spencer CC 

PROVIDER: S-EPMC2688469 | biostudies-literature | 2009 May

REPOSITORIES: biostudies-literature